High prevalence of polymyxin-heteroresistant carbapenem-resistant Klebsiella pneumoniae and its within-host evolution to resistance among critically ill scenarios-Reference-Cited by-同舟云学术

High prevalence of polymyxin-heteroresistant carbapenem-resistant Klebsiella pneumoniae and its within-host evolution to resistance among critically ill scenarios

Published:2024-08-14 Issue: Volume: Page:
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Wang Xiaoli,Meng Tianjiao,Dai Yunqi,Ou Hong-Yu,Wang Meng,Tang Bin,Sun Jingyong,Cheng Decui,Pan Tingting,Tan Ruoming,Qu Hongping

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Clinical science and technology innovation project of SHCD

Guangci discipline group construction of public health and disaster emergency center

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s15010-024-02365-z.pdf

Reference45 articles.

1. Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–27.

2. Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589–601.

3. Liu S, Wu Y, Qi S, et al. Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial. Crit Care. 2023;27(1):232.

4. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022 Guidance on the treatment of extended-spectrum β-lactamase Producing enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat Resistance (DTR-P. aeruginosa). Clin Infect Dis 2022: 187–212.

5. Luo Q, Xu L, Wang Y, et al. Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: a genomic, retrospective cohort study. Clin Microbiol Infect. 2024;30(4):507–14.